153 related articles for article (PubMed ID: 24605944)
1. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.
Li R; Zhang W; Cui J; Shui W; Yin L; Wang Y; Zhang H; Wang N; Wu N; Nan G; Chen X; Wen S; Deng F; Zhang H; Zhou G; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Luu HH; Haydon RC; He TC; Deng ZL
Curr Cancer Drug Targets; 2014; 14(3):274-85. PubMed ID: 24605944
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of BMP9 promotes growth of osteosarcoma mediated by the Notch signaling pathway.
Liu P; Man Y; Wang Y; Bao Y
Oncol Lett; 2016 Feb; 11(2):1367-1370. PubMed ID: 26893744
[TBL] [Abstract][Full Text] [Related]
3. Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs).
Liao J; Wei Q; Zou Y; Fan J; Song D; Cui J; Zhang W; Zhu Y; Ma C; Hu X; Qu X; Chen L; Yu X; Zhang Z; Wang C; Zhao C; Zeng Z; Zhang R; Yan S; Wu T; Wu X; Shu Y; Lei J; Li Y; Luu HH; Lee MJ; Reid RR; Ameer GA; Wolf JM; He TC; Huang W
Cell Physiol Biochem; 2017; 41(5):1905-1923. PubMed ID: 28384643
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
6. BMP9 Promotes the Extracellular Matrix of Nucleus Pulposus Cells via Inhibition of the Notch Signaling Pathway.
Zhang X; Qiao B; Hu Z; Ni W; Guo S; Luo G; Zhang H; Ren H; Zou L; Wang P; Shui W
DNA Cell Biol; 2019 Apr; 38(4):358-366. PubMed ID: 30758228
[TBL] [Abstract][Full Text] [Related]
7. BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells.
Cui J; Zhang W; Huang E; Wang J; Liao J; Li R; Yu X; Zhao C; Zeng Z; Shu Y; Zhang R; Yan S; Lei J; Yang C; Wu K; Wu Y; Huang S; Ji X; Li A; Gong C; Yuan C; Zhang L; Liu W; Huang B; Feng Y; An L; Zhang B; Dai Z; Shen Y; Luo W; Wang X; Huang A; Luu HH; Reid RR; Wolf JM; Thinakaran G; Lee MJ; He TC
Lab Invest; 2019 Jan; 99(1):58-71. PubMed ID: 30353129
[TBL] [Abstract][Full Text] [Related]
8. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation.
Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC
Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling pathway promotes osteogenic differentiation of mesenchymal stem cells by enhancing BMP9/Smad signaling.
Cao J; Wei Y; Lian J; Yang L; Zhang X; Xie J; Liu Q; Luo J; He B; Tang M
Int J Mol Med; 2017 Aug; 40(2):378-388. PubMed ID: 28656211
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.
Zhang J; Liang JH; Huang JG
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706722
[TBL] [Abstract][Full Text] [Related]
11. miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9).
Xie Z; Xu J; Peng L; Gao Y; Zhao H; Qu Y
Biotechnol Lett; 2018 Jan; 40(1):47-55. PubMed ID: 28956179
[TBL] [Abstract][Full Text] [Related]
12. Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression.
Li C; Guo D; Tang B; Zhang Y; Zhang K; Nie L
Neoplasma; 2016; 63(5):734-42. PubMed ID: 27468877
[TBL] [Abstract][Full Text] [Related]
13. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways.
Liu Y; Liu Y; Zhang R; Wang X; Huang F; Yan Z; Nie M; Huang J; Wang Y; Wang Y; Chen L; Yin L; He B; Deng Z
Int J Biochem Cell Biol; 2014 Feb; 47():47-56. PubMed ID: 24300824
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of BMP9 promotes ovarian cancer progression via Notch1 signaling.
Yang L; Bai Y; Zhang C; Du J; Cheng Y; Wang Q; Zhang B; Yang Y
Neoplasma; 2021 Nov; 68(6):1190-1200. PubMed ID: 34533030
[TBL] [Abstract][Full Text] [Related]
16. BMP9 overexpressing adipose-derived mesenchymal stem cells promote cartilage repair in osteoarthritis-affected knee joint via the Notch1/Jagged1 signaling pathway.
Liu X; Du M; Wang Y; Liu S; Liu X
Exp Ther Med; 2018 Dec; 16(6):4623-4631. PubMed ID: 30542413
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling negatively regulates BMP9-induced osteogenic differentiation of mesenchymal progenitor cells by inhibiting JunB expression.
Wang N; Liu W; Tan T; Dong CQ; Lin DY; Zhao J; Yu C; Luo XJ
Oncotarget; 2017 Dec; 8(65):109661-109674. PubMed ID: 29312637
[TBL] [Abstract][Full Text] [Related]
18. Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling.
Cao Y; Yu L; Dai G; Zhang S; Zhang Z; Gao T; Guo W
Eur J Pharmacol; 2017 Jan; 794():77-84. PubMed ID: 27845066
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway Corrigendum in /10.3892/ijo.2019.4817.
Wu N; Li R; Meng Z; Nie M; Chen Q; He B; Deng Z; Yin L
Int J Oncol; 2017 Apr; 50(4):1363-1371. PubMed ID: 28350136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
